Internal Medicine (Preliminary)·Corvallis, OR

Samaritan Health Services - Corvallis

Allocate signal →Track an away here22-26 pooled · applicant-level
Step 2 invited
228–260
p10 – p90
Sample N
-
applicant rows
This cycle
-
no tracked aways yet
Match rate
-
no match data
No visa sponsorshipGraduated within 3 yearsCategoricalPreliminaryRuralHospitalist
Your fitSamaritan Health Services - Corvallis Program

Create a free profile to see your personalized fit

Get started

Who to contact

Training sites7 hospitals
  • 1
    Good Samaritan Regional Medical Center
    Corvallis, OR
    Primary
  • 2
    Samaritan Health Services-Corvallis
    Corvallis, OR
    Sponsor
  • 3
    Firehouse Diabetes and Endocrine Center
    Salem, OR
    Participant
  • 4
    Legacy Good Samaritan Hospital and Medical Center
    Portland, OR
    Participant
  • 5
    Portland Veterans Affairs Medical Center
    Portland, OR
    Participant
  • 6
    Samaritan Albany General Hospital
    Albany, OR
    Participant
  • 7
    Roseburg VA Medical Center
    Roseburg, OR
    Participant
Interview invites
Loading...
Score rangesinvited cohort
USMLE Step 2 CK228 – 260
180205230255280
COMLEX Level 2 CE440 – 645
400500600700800
Interview rates
US MD
29%
US DO
42%
US IMG
2%
Non-US IMG
2%
Signal rates
Gold
61%
Silver
42%
None
16%
Applicant origin
In-state
35%
Out-of-state
24%
Interview prepInternal Medicine (Preliminary)
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Save this program

Add Samaritan Health Services - Corvallis to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for Internal Medicine (Preliminary).

See how your profile compares across all programs.

Open calculator →

Program data, 2025 release. Not medical advice. © 2026 Rezumab LLC.